[go: up one dir, main page]

ES2181387T3 - Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central. - Google Patents

Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.

Info

Publication number
ES2181387T3
ES2181387T3 ES99901781T ES99901781T ES2181387T3 ES 2181387 T3 ES2181387 T3 ES 2181387T3 ES 99901781 T ES99901781 T ES 99901781T ES 99901781 T ES99901781 T ES 99901781T ES 2181387 T3 ES2181387 T3 ES 2181387T3
Authority
ES
Spain
Prior art keywords
treatment
disorders
azetidinocarboxamide
derivatives
nervous system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99901781T
Other languages
English (en)
Inventor
Robin Gerald Shepherd
David Reginald Adams
Jon Bentley
Corinna Dagmar Bodkin
Ian Anthony Cliffe
James Edward Paul Davidson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801499.6A external-priority patent/GB9801499D0/en
Priority claimed from GBGB9824458.5A external-priority patent/GB9824458D0/en
Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd
Application granted granted Critical
Publication of ES2181387T3 publication Critical patent/ES2181387T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un compuesto de fórmula (1) en la que R1 es arilo sustituido con grupos sustituyentes seleccionados entre halo y haloalquilo; y R2 es hidrógeno o alquilo.
ES99901781T 1998-01-23 1999-01-22 Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central. Expired - Lifetime ES2181387T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801499.6A GB9801499D0 (en) 1998-01-23 1998-01-23 Chemical compounds iii
GBGB9824458.5A GB9824458D0 (en) 1998-11-06 1998-11-06 Chemical compounds II

Publications (1)

Publication Number Publication Date
ES2181387T3 true ES2181387T3 (es) 2003-02-16

Family

ID=26313009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99901781T Expired - Lifetime ES2181387T3 (es) 1998-01-23 1999-01-22 Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.

Country Status (10)

Country Link
US (1) US6831078B1 (es)
EP (1) EP1049670B1 (es)
JP (1) JP4542264B2 (es)
AT (1) ATE220665T1 (es)
AU (1) AU2178099A (es)
DE (1) DE69902142T2 (es)
DK (1) DK1049670T3 (es)
ES (1) ES2181387T3 (es)
PT (1) PT1049670E (es)
WO (1) WO1999037613A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917384D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-III
US8586572B2 (en) * 2008-11-24 2013-11-19 Integrative Research Laboratories Sweden Ab 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
CN115650893B (zh) * 2022-10-24 2024-08-06 南通华祥医药科技有限公司 一种1-二苯甲基氮杂环丁烷-3-酮的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872447A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-carbamyl-3-substituted azetidines
US4226861A (en) 1978-04-18 1980-10-07 A. H. Robins Company, Inc. N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
IL68699A (en) 1982-08-19 1986-08-31 Robins Co Inc A H 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
US4505907A (en) 1982-09-02 1985-03-19 A. H. Robins Company, Inc. N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
US4956359A (en) * 1985-02-28 1990-09-11 A. H. Robins Company, Inc. 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics
FI87559C (fi) * 1985-02-28 1993-01-25 Robins Co Inc A H Foerfarande foer framstaellning av aktiva 3-fenyloxiazetidinkarboxamider

Also Published As

Publication number Publication date
EP1049670A1 (en) 2000-11-08
AU2178099A (en) 1999-08-09
EP1049670B1 (en) 2002-07-17
JP4542264B2 (ja) 2010-09-08
DE69902142D1 (de) 2002-08-22
DE69902142T2 (de) 2003-01-09
DK1049670T3 (da) 2002-11-11
ATE220665T1 (de) 2002-08-15
PT1049670E (pt) 2002-12-31
US6831078B1 (en) 2004-12-14
WO1999037613A1 (en) 1999-07-29
JP2002501046A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
PH31123A (en) Benzimidazole compounds.
SE0104332D0 (sv) Therapeutic agents
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
AU2002239463A1 (en) Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indoles as 5ht2c antagonists
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
BR0113389A (pt) Compostos que inibem a atividade do fator xa
DE60102171D1 (de) Ketolidantibiotika
DE60104697D1 (de) Sulfonamid-derivate
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
CA2423628A1 (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
ES2181387T3 (es) Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.
ATE152708T1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
BR0110871A (pt) Derivados de sulfonamida
BG106152A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DE69822937D1 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
ES2193047T3 (es) (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
AP2002002669A0 (en) Hygromycin a derivatives for the treatment of bacterial and protozoal infections.
ECSP992931A (es) Derivados de 2'' desoxi higromicina
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы